Products

JRX Biotech's patented DermXTM MegasphereTM Delivery System can be formulated into existing cosmetic, Over-the-Counter (OTC) or prescription (Rx) formulations in order to create next generation products. Alternatively, JRX scientists have used DermXTM MegasphereTM as a platform from which to formulate world-class finished cosmetic and OTC products.

DermXTM MegasphereTM – Licensed Technology

JRX Biotech licenses its patented DermXTM MegasphereTM technology to marketers, sellers and distributors of cosmetic and OTC products. Potential partners and licensees are interested in using the technology because DermXTM MegasphereTM can:

  • Deliver Large Molecules, and thus increase a product's efficacy, range, and flexibility;
  • Deliver Large Volumes of molecules, and thus produce the desired effect in half the time;
  • Deep Deliver molecules, and thus allow for a longer lasting desired effect; and
  • Deliver molecules Intact, thus mimicking the effect of injections without the pain associated with using a needle.
DermXTM MegasphereTM is ideal for creating "Version 2.0" or premium products, niche formulations, or product line extensions. The technology is also an ideal way to differentiate an existing product in the often crowded and deeply saturated cosmetic and OTC industries.

DermXTM MegasphereTM – In Finished Products

JRX Biotech researchers have formulated numerous finished products using the patented DermXTM MegasphereTM technology platform. Although there are a number of products in the pipeline – from OTC pain relief solutions to next generation anti-aging formulations – the most recognized product is Hydroderm. Hydroderm, developed by JRX researchers, is the best selling anti-wrinkle serum that is powered by the DermXTM MegasphereTM technology.

DermXTM MegasphereTM – In Rx Products

JRX Biotech has internal expertise and experience in formulating the DermXTM MegasphereTM Delivery System into Rx products. DermXTM MegasphereTM can potentially be used in drug applications to:
  • Deliver large molecules,
  • Enhance efficacy,
  • Extend patent life, and
  • Extend drug product life cycles.